ReproMed – REPR – Measured Risk With Big Potential Reward
We believe that REPRO MED SYS INC (OOTC:REPR) can more than double from its recent trading price, but there are risks. [...]
Horton Capital Continues to Buy Shares of Repro-Med – REPR
We have been highlighting the continuous open market purchases of Repro-Med Systems (OOTC:REPR) shares by Joseph Manko of Horton Capital Management [...]
Repro-Med Systems – REPR – Stock Price Matches 52 Week High, Closes in on 16 Year High
GeoInvesting has been covering Repro-Med Systems (OOTC:REPR) for several years and in mid 2014, we explained that the company's history of [...]
Challenge Turns into Opportunity for Repro-Med Systems – REPR
The GeoTeam has been monitoring developments that might impact REPRO MED SYS INC (OOTC:REPR) and its flagship product, the FREEDOM60 pump [...]
Marina Biotech – MRNA: A Forgotten And Grossly Undervalued Game Changer
Summary Trading at less than a quarter of valuation of its closest peer that was acquired by Roche in August [...]
22nd Century Group (XXII) – A Lot Of Smoke, Not Enough Fire
Summary A number of factors lead us to the conclusion that 22nd Century Group (XXII) is severely overvalued and likely [...]
New Due Diligence Strengthens Short Thesis On American Heritage
Summary AHII Reverse merger filings appear to mask the involvement of Daryl O. Anderson, one of the players in the [...]
Aegerion Pharmaceuticals (AEGR) Viability Threatened As Regulatory, Legal And Market Forces Close In
It's not often that evidence gathered in one of our investigations into a company that is not a classic pump [...]